HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype
- 17 April 2007
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 104 (16), 6776-6781
- https://doi.org/10.1073/pnas.0611244104
Abstract
Some rare HIV-1-infected individuals, referred to as HIV controllers (HIC), have persistently undetectable plasma viral load in the absence of therapy. This control of HIV-1 replication has been associated with a strong, multifunctional specific CD8(+) T cell response. However, no direct link between this immune response and the control of viremia has so far been provided. We investigated parameters of specific CD8(+) T cell response and in vitro susceptibility to HIV-1 infection in 11 HIC. We found high frequencies of HIV-specific CD8(+) T cells. Interestingly, these cells expressed the activation marker HLA-DR but not CD38. This unique phenotype differentiates HIV-specific CD8(+) T cells from HIC and noncontroller subjects and likely reflects a high potential to expand upon exposure to antigen and a capacity to exert effector functions. Accordingly, although CD4(+) T cells from HIC were fully susceptible to HIV-1 superinfection, their CD8(+) T cells effectively suppressed HIV-1 infection. Remarkably, this potent anti-HIV activity was observed without prior stimulation of CD8(+) T cells. This activity was not mediated by secreted inhibitory factors but was due to the elimination of infected CD4(+) T cells and was observed only with autologous CD4(+) T cells, indicating an HLA-restricted cytotoxic mechanism. This constitutive antiviral capacity of CD8(+) T cells could account for the control of viral replication in HIC.Keywords
This publication has 37 references indexed in Scilit:
- Quantitative real-time analysis of HIV-1 gene expression dynamics in single living primary cellsBiotechnology Journal, 2006
- Maintenance of viral suppression in HIV-1–infected HLA-B*57+ elite suppressors despite CTL escape mutationsThe Journal of Experimental Medicine, 2006
- Immune Activation and CD8+ T-Cell Differentiation towards Senescence in HIV-1 InfectionPLoS Biology, 2004
- Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8+ T cellsBlood, 2003
- Impact of Antiretroviral Therapy and Changes in Virus Load on Human Immunodeficiency Virus (HIV)–Specific T Cell Responses in Primary HIV InfectionThe Journal of Infectious Diseases, 2003
- G Protein-Dependent CCR5 Signaling Is Not Required for Efficient Infection of Primary T Lymphocytes and Macrophages by R5 Human Immunodeficiency Virus Type 1 IsolatesJournal of Virology, 2003
- Human CD8+ T cells expressing HLA-DR and CD28 show telomerase activity and are distinct from cytolytic effector T cellsEuropean Journal of Immunology, 2001
- HIV-Specific Cd8+ T Cells Produce Antiviral Cytokines but Are Impaired in Cytolytic FunctionThe Journal of Experimental Medicine, 2000
- Identification of RANTES, MIP-1α, and MIP-1β as the Major HIV-Suppressive Factors Produced by CD8 + T CellsScience, 1995
- Cytotoxic T lymphocytes against HIVAIDS, 1990